Microbot Medical Inc.

NasdaqCM:MBOT Voorraadrapport

Marktkapitalisatie: US$15.6m

Microbot Medical Inkomsten in het verleden

Verleden criteriumcontroles 0/6

Microbot Medical's earnings have been declining at an average annual rate of -9.6%, while the Medical Equipment industry saw earnings growing at 12.9% annually.

Belangrijke informatie

-9.6%

Groei van de winst

5.9%

Groei van de winst per aandeel

Medical Equipment Groei van de industrie8.9%
Inkomstengroein/a
Rendement op eigen vermogen-172.4%
Nettomargen/a
Laatste winstupdate30 Jun 2024

Recente prestatie-updates uit het verleden

Geen updates

Recent updates

Is Microbot Medical (NASDAQ:MBOT) In A Good Position To Invest In Growth?

Dec 30
Is Microbot Medical (NASDAQ:MBOT) In A Good Position To Invest In Growth?

Is Microbot Medical (NASDAQ:MBOT) In A Good Position To Invest In Growth?

Sep 01
Is Microbot Medical (NASDAQ:MBOT) In A Good Position To Invest In Growth?

Here's Why We're A Bit Worried About Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation

Dec 28
Here's Why We're A Bit Worried About Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation

Microbot Medical acquires Nitiloop, terms undisclosed

Oct 07

Here's Why We're Watching Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation

Sep 13
Here's Why We're Watching Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation

Microbot Medical confirms GLP trial on track to begin later this month

Sep 02

Will Microbot Medical (NASDAQ:MBOT) Spend Its Cash Wisely?

Apr 23
Will Microbot Medical (NASDAQ:MBOT) Spend Its Cash Wisely?

Microbot Medical's Stryker Collaboration Makes This An Intriguing High Flier

Jan 06

Companies Like Microbot Medical (NASDAQ:MBOT) Are In A Position To Invest In Growth

Dec 24
Companies Like Microbot Medical (NASDAQ:MBOT) Are In A Position To Invest In Growth

We Think Microbot Medical (NASDAQ:MBOT) Can Afford To Drive Business Growth

Aug 27
We Think Microbot Medical (NASDAQ:MBOT) Can Afford To Drive Business Growth

Companies Like Microbot Medical (NASDAQ:MBOT) Are In A Position To Invest In Growth

May 12
Companies Like Microbot Medical (NASDAQ:MBOT) Are In A Position To Invest In Growth

We Think Microbot Medical (NASDAQ:MBOT) Can Afford To Drive Business Growth

Jan 27
We Think Microbot Medical (NASDAQ:MBOT) Can Afford To Drive Business Growth

Microbot Medical's study of surgical robotic system meets endpoints

Jan 14

Opbrengsten en kosten

Hoe Microbot Medical geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

NasdaqCM:MBOT Opbrengsten, kosten en inkomsten (USD Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 240-1045
31 Mar 240-1045
31 Dec 230-1146
30 Sep 230-1156
30 Jun 230-1257
31 Mar 230-1367
31 Dec 220-1368
30 Sep 220-1468
30 Jun 220-1367
31 Mar 220-1267
31 Dec 210-1156
30 Sep 210-1055
30 Jun 210-1064
31 Mar 210-964
31 Dec 200-963
30 Sep 200-853
30 Jun 200-853
31 Mar 200-753
31 Dec 190-743
30 Sep 190-853
30 Jun 190-753
31 Mar 190-852
31 Dec 180-752
30 Sep 180-752
30 Jun 180-642
31 Mar 180-841
31 Dec 170-841
30 Sep 170-14101
30 Jun 170-14111
31 Mar 170-11101
31 Dec 160-1091
30 Sep 160-211
30 Jun 160-101
31 Mar 160-101
31 Dec 150-101
31 Dec 140-101

Kwaliteitswinsten: MBOT is currently unprofitable.

Groeiende winstmarge: MBOT is currently unprofitable.


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: MBOT is unprofitable, and losses have increased over the past 5 years at a rate of 9.6% per year.

Versnelling van de groei: Unable to compare MBOT's earnings growth over the past year to its 5-year average as it is currently unprofitable

Winst versus industrie: MBOT is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (11.7%).


Rendement op eigen vermogen

Hoge ROE: MBOT has a negative Return on Equity (-172.35%), as it is currently unprofitable.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden